Can Pharma Make a Business Case for Social Media? (2008 Digital Pharma Presentaiton)

by 6 Comments »
For those of you who have been patiently waiting and requesting for the slides from my recent presentation at #DigPharma08, entitled “Can Pharma Make a Business Case for Social Media”, I am happy to tell you that I have finally uploaded them to Slideshare and embedded them below.
Can Pharma Make a Business Case for Social Media
View SlideShare presentation or Upload your own. (tags: #digpharma08 pharmer)

It took me a while to clean up the slides, not so much in terms of the actual content, but more on the visuals, numbers, and attributions. Here’s a list of the major changes from the original presentation:

  • Edited images that were blur and/or would not display on PC
  • Replaced images that were NOT covered by a Creative Commons license
  • Removed embedded videos
  • Added some details to MS Academy Mobile case in place of video
  • Added resource links and contact details at end of presentation

As you can see, none of the changes significantly affected the main content that was presented, so it’s pretty much the same deck with a few minor adjustments for “public release”. The sections/topics I cover in this presentation are still the following:

  1. What is Social Media?
  2. What are the main hurdles?
  3. Why is it important?
  4. Where does it fit in?
  5. How do I get started?
  6. What strategies can we use?
  7. How about regulatory concerns?
  8. What about ROI?
  9. Final Thoughts

Over the next few weeks, I hope to cover each of the sections in more detail via this blog, so do keep a look out. In the mean time, feel free to send an email or tweet (@shwen) with any questions or leave me a comment about them. Would love to hear your feedback!

Also, if you attended the Digital Pharma conference and/or are thinking about attending Digital Pharma 2009, please send me your thoughts, ideas, feedback on what value and opportunities you would like to experience at this conference. Since I am chairing it next year, I hope to really bring the voice of the participants into the development of the conference program!

NOTE: I have decided to cover the presentaiton under a Creative Commons Attribution and Share Alike license.

Share

BMS and Novartis Provide Unrestricted Grants to Social Media Initiatives

by 7 Comments »


According to the
Pharma 2.0 Blog, “Bristol-Myers Squibb provided unrestricted funding to facilitate the launch of a new site for women with advanced breast cancer“.

The Advanced Breast Cancer Community launched in early September offering both an information gateway and social network for the advanced/metastatic breast cancer community…
As one user commented, “Early on in my diagnosis I perused many Internet sites that just left me more confused, scared and depressed than I already was. So I gave up looking. Until something brought me to this site just yesterday. What a great place. I can tell already that this is the place where I want to hang out.”

The site was built by Inspire which “…builds and manages online communities in which thousands of patients, family members and caregivers support and communicate with one another in safe, secure, privacy- protected environments“.

Most Inspire communities are built for free and operate under the auspices of some of the most respected nonprofit health organizations in the US. Our nonprofit partners include such distinguished organizations as the ALS Association, Arthritis Foundation, Lung Cancer Alliance, National Organization of Rare Disorders, and the National Osteoporosis Foundation, among others.

I think it’s a really good sign that pharmaceutical companies are starting to recognize the value and importance that online communities and other social media efforts can have in supporting patients, caregivers, and even healthcare professionals.

In fact, this isn’t first unrestricted grant that I’ve heard of from a pharma company to a non-profit social media initiative. Just a few weeks ago at the Digital Pharma conference, I was speaking with Matt Zachary — Founder and CEO of I’m Too Young For This (i2y) — who told me that Novartis Oncology had provided an unrestricted grant to them for their on and off -line initiatives that support young adults affected by cancer. Looks like they also got support from MGI Pharma, GSK, Schering-Plough and a bunch other non-pharma related organizations (including Heineken!!!).

Here’s a list of various i2y programs that tries to help “empower young adults affected by cancer by ending isolation, improving quality of life and providing meaningful survivorship“:

Considering that the i2y slogan and campaign is “Stupid Cancer”, you would think that traditionalists would exclude them from funding or even a consideration just by the mere fact that it’s not titled something more “professional” or that many of their efforts are based in social media. So I’m really glad to see that neither the social media aspect nor the slogan has turned off support for this truly important network — well done to the funding bodies for not letting these issues get in the way of initiatives that really work and really support a good cause!

Share
WP Theme & Icons by N.Design Studio
Entries RSS Comments RSS Log in